Publications by authors named "Michael Oestergaard"

Claim this Profile
C
Central Nervous System Biodistribution and Pharmacokinetics of Radiolabeled Tofersen in Rodents, Nonhuman Primates, and Humans.
Brendon E Cook, Donald G McLaren, Jenna M Sullivan, Georges El Fakhri, Daniel L Yokell, Michael E Oestergaard

J Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards combining backbone and sugar constraint in 3'-3' bis-phosphonate tethered 2'-4' bridged LNA oligonucleotide trimers.
Edouard Duchamp, Guillermo Vasquez, Neda Firoozi, Graeme C Freestone, Michael Oestergaard

RSC Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in mice.
Alfred E Chappell, Hans J Gaus, Andres Berdeja, Ruchi Gupta, Minji Jo, Michael Oestergaard

Nucleic Acids Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma.
Sakiko Yoshida, Connie Duong, Michael Oestergaard, Michael Fazio, Cathy Chen

Nanomedicine· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging.
Curt Mazur, Berit Powers, Kenneth Zasadny, Jenna M Sullivan, Hemi Dimant, Michael Oestergaard

JCI Insight· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins.
Michael T Migawa, Wen Shen, W Brad Wan, Guillermo Vasquez, Michael E Oestergaard

Nucleic Acids Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate.
Noriko Satake, Connie Duong, Sakiko Yoshida, Michael Oestergaard, Cathy Chen

Mol Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis